RoSA PCR-based Infectious Diseases Market to 2032
Overview
The RoSA PCR-based Infectious Diseases Market is expected to reach a 149.50 USD Million by 2032 and is projected to grow at a CAGR of 5.01% from 2025 to 2032.
Revenue, 2024 (USD Million)
108.40
Forecast, 2032 (USD Million)
149.50
CAGR, 2024 - 2032
5.01%
Report Coverage
RoSA
RoSA PCR-based Infectious Diseases Market 2018-2032 USD Million
RoSA PCR-based Infectious Diseases Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 108.40 USD Million
- Projected Market Size (2032): 149.50 USD Million
- CAGR (2025-2032): 5.01%
Key Findings of RoSA PCR-based Infectious Diseases Market
- The RoSA PCR-based Infectious Diseases Market was valued at 108.40 USD Million in 2024.
- The RoSA PCR-based Infectious Diseases Market is likely to grow at a CAGR of 5.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 67.23 USD Million
- The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 7.34% during the forecast period from 2024 to 2032.
RoSA PCR-based Infectious Diseases Market Scope
RoSA PCR-based Infectious Diseases Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
RoSA PCR-based Infectious Diseases Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 108.40 USD Million |
| Market Value in 2032 | 149.50 USD Million |
| CAGR (2025-2032) | 5.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Testing,Infection,Patient Type,PCR Technology,Pathogen,Test Type |
Regional Insights:
-
Leading Market (2024-2032): RoSA, leading in terms of revenue 108.40 USD Million in 2024
- Key Country: RoSA, leading in terms of revenue with value of 108.40 USD Million in 2024.
Segments and Scope
-
RoSA PCR-based Infectious Diseases Market to 2032, By End User
- Diagnostic Centers is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 28.76 USD Million in the year 2024.
- Diagnostic Centers is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 6.69 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By Testing
- Laboratory Based Testing is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 67.23 USD Million in the year 2024.
- Laboratory Based Testing is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.28 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By Infection
- Viral Infection is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 46.61 USD Million in the year 2024.
- Viral Infection is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.64 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By Patient Type
- Geriatric is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 44.87 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.77 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By PCR Technology
- RT PCR is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 46.15 USD Million in the year 2024.
- RT PCR is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.79 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By Pathogen
- Viral is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 44.58 USD Million in the year 2024.
- Viral is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 5.38 % in forecast period 2025-2032.
-
RoSA PCR-based Infectious Diseases Market to 2032, By Test Type
- Tuberculosis PCR Test is the largest segment in RoSA PCR-based Infectious Diseases Market to 2032 with a revenue of 13.92 USD Million in the year 2024.
- Tuberculosis PCR Test is the Fastest growing segment in RoSA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.34 % in forecast period 2025-2032.
RoSA PCR-based Infectious Diseases Market Company Share Analysis
RoSA PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million
RoSA PCR-based Infectious Diseases Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoSA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Infection,Patient Type,PCR Technology,Pathogen,Test Type.
RoSA PCR-based Infectious Diseases Market was valued at USD 108.40(Revenue in USD Million) in 2022.
RoSA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.01% during the forecast period of 2024 to 2032.
The Laboratory Based Testing segment is expected to dominate the RoSA PCR-based Infectious Diseases Market, holding a largest market share of 67.23 USD Million in 2024
RoSA PCR-based Infectious Diseases Market Scope
RoSA PCR-based Infectious Diseases Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
Frequently Asked Questions
The RoSA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Infection,Patient Type,PCR Technology,Pathogen,Test Type.
RoSA PCR-based Infectious Diseases Market was valued at USD 108.40(Revenue in USD Million) in 2022.
RoSA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.01% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA PCR-based Infectious Diseases Market for final year is USD 149.50 (USD Million).
RoSA PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The RoSA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Infection,Patient Type,PCR Technology,Pathogen,Test Type.
RoSA PCR-based Infectious Diseases Market was valued at USD 108.40(Revenue in USD Million) in 2022.
RoSA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 5.01% during the forecast period of 2024 to 2032.
The estimated market value of the RoSA PCR-based Infectious Diseases Market for final year is USD 149.50 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.